Serum beta-2-microglobulin in Sjögren's syndrome

Area of Science:

• Immunology
• Ophthalmology
• Rheumatology

Background:

• Keratoconjunctivitis sicca (KCS) is a common ocular surface disease.
• Sjögren's syndrome is an autoimmune disorder often associated with KCS.
• Beta-2-microglobulin (B2M) is a protein found on cell surfaces, and its serum levels can indicate immune system activity.

Purpose of the Study:

• To investigate the serum concentration of beta-2-microglobulin (B2M) in patients with KCS.
• To determine the association between B2M levels and Sjögren's syndrome.
• To explore correlations between high B2M levels and clinical characteristics in KCS patients.

Main Methods:

• Radioimmunoassay was used to measure serum B2M levels.
• The study included 52 patients diagnosed with KCS.
• A subgroup of 29 patients had diagnosed Sjögren's syndrome.

Main Results:

• Eleven (38%) of the Sjögren's syndrome patients exhibited high serum B2M values.
• High B2M levels were associated with older mean age and a higher frequency of the complete Sjögren's triad.
• High B2M levels also correlated with the presence of antinuclear antibodies.
• The sicca components alone did not significantly influence serum B2M concentrations.
• Most observed complications occurred in patients with elevated B2M levels.

Conclusions:

• Elevated serum B2M may be a marker for a more severe or advanced form of Sjögren's syndrome.
• B2M levels in KCS patients are influenced by the presence of Sjögren's syndrome and associated autoimmune markers.
• Further research is warranted to explore the prognostic value of B2M in KCS and Sjögren's syndrome.